About the Centre

The Centre of Excellence in Cellular Immunotherapy is a fully funded program that will commit funds to co-develop and manufacture innovative, cell-based immunotherapy concepts with our partners for rapid translation into pilot clinical trials with potential for commercial outcomes

Through translation of novel cell-based immunotherapies, the Centre of Excellence in Cellular Immunotherapy will facilitate early and affordable access of these practice-changing therapies for cancer patients in Australia and the wider Asia-Pacific region. Development of, and access to these therapies will come from increased focus and capacity of three avenues within the centre:

Centre of Excellence in Cellular Immunotherapy

Building increased capabilities and capacities to advance cancer care 

The Centre is funded by a co-investment from the Federal Government, Cell Therapies Pty Ltd and the Peter MacCallum Cancer Foundation. This capital funding has been used to increase capabilities over the Centre's 3 pillars of excellence:

The Centre is supported by partners in various health sectors who, in total, enable the centre to provide access to innovative patient care.

 Centre of Excellence in Cellular Immunotherapy

Goals of the Centre of Excellence in Cellular Immunotherapy 

  • Increase the capability of clinical trials, building on Peter Mac’s current trials in adoptive immunotherapy. 

  • Create a new Australian bio-manufacturing industry centred in Melbourne by identifying and supporting new research and development. 

  • Increase capital investment for the development of a national centre that will provide standard of care and advance novel cellular immunotherapy treatments. 

  • Create commercial opportunities for innovative Australian research, based on protecting new IP (Intellectual Property). 

Related pages